About Cellera

Cellera Farma is the result of Delta Pharmaceuticals and the company MIP Brasil Farma acquisition, with the Principia Capital Partners group investment in partnership with Omilton Visconde Jr., a businessman with great experience in the Brazilian pharmaceutical market. See our timeline: